Cancer
Gastric Cancer Research Reveals New Insights on Zolbetuximab-Induced Gastritis
Researchers at the National Cancer Center Hospital East in Chiba, Japan, have made significant discoveries regarding the adverse effects of zolbetuximab, a monoclonal antibody used in the treatment of CLDN18.2-positive advanced gastric cancer. The study, published in ESMO Open, highlights the incidence and characteristics of gastritis in patients undergoing